Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML)
Clinical trial NCT01218477 · COMPLETED
Trial details
- NCT number
- NCT01218477
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2013-04-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.